다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

홈
인베스팅
주식
영국
LSE
Hutchmed (china) Limited (HCM)
Hutchmed (china) Limited (HCM) 뉴스

HCM

Hutchmed (china) (HCM)

Hutchmed (china) Limited

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:LSE:HCM

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/17	18:32	Alliance News	Hutchmed celebrates "promising" results for sovleplenib in China	LSE:HCM	Hutchmed (china) Limited
2024/06/17	15:00	RNS Non-Regulatory	Hutchmed (China) Limited Lancet Publish Phase III ESLIM-01 Results	LSE:HCM	Hutchmed (china) Limited
2024/06/08	02:13	Alliance News	IN BRIEF: Hutchmed (China) begins trial of menin inhibitor HMPL-506	LSE:HCM	Hutchmed (china) Limited
2024/06/07	15:00	RNS Non-Regulatory	Hutchmed (China) Limited HUTCHMED Initiates Phase I Trial of HMPL-506	LSE:HCM	Hutchmed (china) Limited
2024/06/03	15:00	RNS Non-Regulatory	Hutchmed (China) Limited Nature Medicine Publish Phase III FRUTIGA Results	LSE:HCM	Hutchmed (china) Limited
2024/05/31	17:30	RNS Regulatory News	Hutchmed (China) Limited Total Voting Rights	LSE:HCM	Hutchmed (china) Limited
2024/05/24	15:00	RNS Non-Regulatory	Hutchmed (China) Limited HUTCHMED Presentations at 2024 ASCO Annual Meeting	LSE:HCM	Hutchmed (china) Limited
2024/05/18	01:58	Alliance News	IN BRIEF: Hutchmed China Simon To leaves role, succeeded by Dan Eldar	LSE:HCM	Hutchmed (china) Limited
2024/05/17	23:00	RNS Regulatory News	Hutchmed (China) Limited Retirement of Chairman and new Chairman appointed	LSE:HCM	Hutchmed (china) Limited
2024/05/17	15:00	RNS Non-Regulatory	Hutchmed (China) Limited HUTCHMED Data to be Presented at EHA2024 Congress	LSE:HCM	Hutchmed (china) Limited
2024/05/14	22:33	Alliance News	Hutchmed announces trials of HMPL-306 and Surufatinib cancer therapies	LSE:HCM	Hutchmed (china) Limited
2024/05/14	15:00	RNS Non-Regulatory	Hutchmed (China) Limited HUTCHMED Initiates Registrational Phase III Trial	LSE:HCM	Hutchmed (china) Limited
2024/05/14	15:00	RNS Non-Regulatory	Hutchmed (China) Limited HUTCHMED Initiates Phase II/III Trial with Hengrui	LSE:HCM	Hutchmed (china) Limited
2024/05/10	21:00	RNS Regulatory News	Hutchmed (China) Limited Result of AGM	LSE:HCM	Hutchmed (china) Limited
2024/05/08	17:30	RNS Regulatory News	Hutchmed (China) Limited Directorate Change	LSE:HCM	Hutchmed (china) Limited
2024/04/27	00:09	Alliance News	Hutchmed notes CHMP's positive opinion for fruiquintinib approval	LSE:HCM	Hutchmed (china) Limited
2024/04/26	21:30	RNS Regulatory News	Hutchmed (China) Limited Positive CHMP Opinion for Fruquintinib	LSE:HCM	Hutchmed (china) Limited
2024/04/22	17:30	RNS Regulatory News	Hutchmed (China) Limited Vesting of Awards Under the LTIP	LSE:HCM	Hutchmed (china) Limited
2024/04/08	17:30	RNS Regulatory News	Hutchmed (China) Limited 2023 Annual Report and Notice of AGM	LSE:HCM	Hutchmed (china) Limited
2024/04/05	17:30	RNS Non-Regulatory	Hutchmed (China) Limited Data to be Presented at AACR Congress 2024	LSE:HCM	Hutchmed (china) Limited
2024/04/02	18:32	Alliance News	Hutchmed endometrial cancer treatment application accepted for review	LSE:HCM	Hutchmed (china) Limited
2024/04/02	15:00	RNS Non-Regulatory	Hutchmed (China) Limited HUTCHMED and Innovent Announce NDA Acceptance	LSE:HCM	Hutchmed (china) Limited
2024/03/28	20:08	Alliance News	Hutchmed lung cancer treatment accepted for review in China	LSE:HCM	Hutchmed (china) Limited
2024/03/28	16:00	RNS Non-Regulatory	Hutchmed (China) Limited Savolitinib sNDA Accepted in China	LSE:HCM	Hutchmed (china) Limited
2024/03/22	19:09	Alliance News	Hutchmed begins registration stage for sovleplenib phase 2/3 trial	LSE:HCM	Hutchmed (china) Limited
2024/03/22	16:16	Alliance News	*CORRECT: Hutchmed China initiates registration for phase 3 trials of sovleplenib	LSE:HCM	Hutchmed (china) Limited
2024/03/22	16:00	RNS Non-Regulatory	Hutchmed (China) Limited Initiation of Registration Stage of P2/3 Trial	LSE:HCM	Hutchmed (china) Limited
2024/03/14	18:00	RNS Regulatory News	Hutchmed (China) Limited LTIP and Share Option Scheme	LSE:HCM	Hutchmed (china) Limited
2024/03/05	17:30	RNS Regulatory News	Hutchmed (China) Limited Vesting of awards under the LTIP	LSE:HCM	Hutchmed (china) Limited
2024/02/29	02:31	Alliance News	EARNINGS: Hutchmed revenue surges, Craven House's loss widens	LSE:HCM	Hutchmed (china) Limited

검색 관련기사 보기:LSE:HCM

1 2 3 4 5 6 7 8 9 10 다음 >>

Lithos Energy (PK)

SG Issuer Sg Issuer Fx J...

FT Vest US Equity Modera...

Citius Pharmaceuticals

LifeX Income Fund 1952M

White Rock Minerals (PK)

Freegold Ventures

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관